Kakadia, S., Yarlagadda, N., Awad, R., Kundranda, M., Niu, J., Naraev, B., . . . Mahmoud, F. (2018). Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma. Onco Targets Ther.
Chicago Style CitationKakadia, Sunilkumar, et al. "Mechanisms of Resistance to BRAF and MEK Inhibitors and Clinical Update of US Food and Drug Administration-approved Targeted Therapy in Advanced Melanoma." Onco Targets Ther 2018.
Cita MLAKakadia, Sunilkumar, et al. "Mechanisms of Resistance to BRAF and MEK Inhibitors and Clinical Update of US Food and Drug Administration-approved Targeted Therapy in Advanced Melanoma." Onco Targets Ther 2018.
Atenció: Aquestes cites poden no estar 100% correctes.